Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Johnson & Johnson (JNJ) , which belongs to the Zacks Large Cap Pharmaceuticals industry, could be a great candidate to consider.When looking at the last two reports, this world's biggest maker of health care products has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 3.22%, on average, in the last two qua ...